TrialX
Image

Evaluate the Safety and Efficacy of Botulax in Subjects With Benign Masseteric Hypertrophy

Evaluate the Safety and Efficacy of Botulax in Subjects With Benign Masseteric Hypertrophy

Recruiting
19 years and older
All
Phase 2

Overview

This study is A Randomized, Double-blind, Placebo-controlled, Multi-center Phase II Optimal Dose-finding Study to Evaluate the Safety and Efficacy of Botulax in Subjects with Benign Masseteric Hypertrophy

Description

A Randomized, Double-blind, Placebo-controlled, Multi-center Phase Optimal Dose-finding Study to Evaluate the Safety and Efficacy of Botulax in Subjects with Benign Masseteric Hypertrophy

Eligibility

Inclusion Criteria:

  1. Male and Female adults aged 19 or older.
  2. Sighting, facilitation measurement are judged by the investigator to be the ratio of Benign Masseteric Hypertrophy.
  3. Subject who understand and willing to perform with the procedures and visiting schedules of clinical trial.
  4. Subject who voluntarily agree to participate in this clinical trial.

Exclusion Criteria:

  1. Subject who is clinically significant facial asymmetry in visual measurement by the investigator.
  2. Fertile women and men who have plans to conceive during pregnancy, breastfeeding and clinical trials or who do not agree to appropriate contraception.
  3. Subject who is deemed unable to participate in a clinical trial under the judgement of a Investigator.

Study details
    Benign Masseteric Hypertrophy

NCT04443244

Hugel

16 February 2024

Contact a study center
Step 1 Get in touch with the nearest study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.